Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis

NCT04844359 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT04844359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04844359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
Lead sponsor
National Jewish Health
Phase
Observational
Overall status
Active, not recruiting
Start date
January 6, 2021
Completion date
July 31, 2026
Enrollment
137 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hypersensitivity pneumonitis